Low-intensity extracorporeal shockwave therapy (LI_ESWT) as a novel treatment for diabetic kidney disease: Results from two prospective studies

Sune Møller Jeppesen, Knud Bonnet Yderstræde, Claus Bistrup, Boye L. Jensen, Milad Hanna, Aleksandre Bochorishvili, Andro Dzneladze, George Botchorishvili, Lars Lund

Research output: Contribution to journalConference abstract in journalResearchpeer-review

4 Downloads (Pure)


Low-intensity extracorporeal shockwave therapy (li-ESWT) is a novel treatment to stimulate tissue remodeling and regeneration. Animal studies have demonstrated
local upregulation of eNOS and VEGF leading to angiogenesis and improved renal function in ischemia reperfusion kidney injury treated with li-ESWT. We tested the hypothesis that li-ESWT would improve glomerular filtration rate (GFR) and reduce urinary albumin excretion (UAE) in patients with diabetic kidney disease (DKD).
Original languageEnglish
Article numberPD30-04
JournalThe Journal of Urology
Issue number4 Supplement
Pages (from-to)e625
Number of pages1
Publication statusPublished - 16. May 2020

Cite this